Clinical Trial Update: Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated adding everolimus to cisplatin and paclitaxel for stage II/III breast cancer. The study has completed, and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Afinitor (everolimus)
• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-05-07